ArticleJournal of the Intensive Care Society2026
The LoVe score: Development and validation of a bedside clinical index to identify patients at risk for prolonged invasive mechanical ventilation.
Article in Journal of the Intensive Care Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early management decisions after intubation, such as humidification strategy or initiation of prevention bundles for ventilator-associated pneumonia, often depend on the expected duration of invasive mechanical ventilation (IMV). However, no simple, standardised method exists to support such estimates at the bedside. We aimed to develop and validate the Length of Ventilation (LoVe) index, a score to predict prolonged IMV beyond 48 h using peri-intubation data. Methods: We conducted a retrospective cohort study using two large, publicly available ICU databases: AmsterdamUMCdb for model development and internal validation, and MIMIC-IV for external validation. The primary outcome was prolonged IMV, defined as support beyond 48 h or death within 48 h. Two LoVe variants were derived: a ventilator-inclusive version incorporating ventilator settings, and a ventilator-agnostic version without ventilator settings. Predictors identified via logistic regression were discretised into clinically interpretable ranges and summed into an additive score. Clinical utility was assessed using decision curve analysis. Results: In the cardiac surgery and non-cardiac surgery cohorts, the ventilator-inclusive LoVe index achieved AUROC scores of 0.82 and 0.75, respectively. The ventilator-agnostic version reached 0.72 in the non-cardiac surgery cohort. Validation in MIMIC-IV yielded 0.71 and 0.68 for the ventilator-inclusive version, and 0.71 and 0.65 for the ventilator-agnostic index. Decision curve analysis demonstrated that both LoVe indices provided meaningful clinical utility. Conclusions: The LoVe index provides a simple, interpretable bedside tool to estimate the likelihood of prolonged IMV early after intubation, showing consistent external validity and potential to support early ICU decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.